By December 1971, 10,000 Beall Teflon disc mitral valve prostheses had been delivered by the manufacturers. There are a number of reports of the results of mitral valve replacement with this prosthesis which testify to the haemodynamic acceptability of the valve (Linhart et al., 1969 ; Vogel et al., 1971) and the low incidence of early and late postoperative thromboembolic episodes (Beall et al., 1968 ; Javier et al., 1970) . Disc variance, reported as a complication of those valves manufactured before 1968, the disc of which was of extruded Teflon (Beall, Bricker, and Messmer, 1970; Robinson, Hildner, and Greenberg, 1971) , was thought to be less likely when the disc was replaced by a significantly more dense, compression-moulded Teflon twice as thick as that previously used. However, Berroya and Escano (1972) report two examples of variance of the newer, thicker, compression-moulded discs. Still more recently, the problem of disc variance is believed to have been overcome by the use of Pyrolite carbon (Beall et al., 1972) .
While accepting that the valve is now likely to be durable, that the thromboembolic complication rate is low, and that the haemodynamic efficiency, at least at rest, is adequate, the haemolytic effects of the valve are less acceptable (Williams et al., 1971) . Haemolysis has long been recognized as a complication of prosthetic valve replacement, and this problem was recently summarized in an editorial in the Lancet (1972) . Minor degrees of haemolysis are known to occur with all varieties of prosthetic valve, especially in the aortic position, and when more than one valve is replaced. Clinically significant haemolysis has, however, been unusual without partial detachment of a prosthesis and perivalvular incompetence. There is strong evidence that valve prostheses which incorporate Dacron velour predispose to excessive intravascular haemolysis in the absence of prosthetic dysfunction or incompetence, both in patients (Milam, Bloodwell, Hallman, and Cooley, 1969) and in experimental animals (Magovern et al., 1970) , and the haemolytic effects of Dacron velour heavily outweigh the incompletely proven advantages of rapid tissue ingrowth in this material.
The purpose of this paper is to outline clinical experience of valve replacement with the Beall In all patients the management of bypass was standard, using a haemodilution technique, a bubble (Temptrol or Travenol) oxygenator, and normal temperature. The duration of bypass varied from 21 to 60 minutes, and average bypass duration was 36 minutes. In most of the operations undertaken through a right thoracotomy the aorta was accessible for arterial inflow cannulation. The aorta was clamped between the valve and cannula during the period of left atriotomy, which was sited in front of the right pulmonary veins, and inspection and excision of the mitral valve. The aortic valve was then tripped and the aorta unclamped during placement of the sutures in the mitral annulus; the clamp was reapplied during seating of the valve. After all sutures had been tied, the disc was tripped, the left atrium partly repaired, and the cardiac chambers emptied of air, a manoeuvre which included aspiration of the base of the aorta, following which the aortic clamp was removed. Finally the trip was removed and the left atrial repair was completed. In those patients in whom mitral valve replacement was undertaken through a left thora-cotomy, venous drainage was from the left femoral vein and the right ventricular outflow, and the arterial inflow was to the left femoral artery. Aortic clamping for the control of air followed the same routine as through a right thoracotomy; a left ventricular vent was used.
During the period when 60 Beall valves were inserted in 59 patients the mitral valve was replaced in 43 patients using a Starr-Edwards prosthesis and in 11 patients using homograft valves by the same group of surgeons and with a similar technique.
RESULTS
There was one operative and one early postoperative death; there have not been late postoperative deaths. The intraoperative death can be related directly to surgical error. The early postoperative death was the consequence of massive haemolysis, acute renal failure, and arrhythmia related to a rapidly rising blood potassium. Death occurred while preparations were being made for haemodialysis. This patient was the second in this series.
In 29 patients haemolysis occurred in early convalescence, never earlier that four hours after the end of bypass, unrelated to time on bypass and valve size, sex or age of patient. The patientshalf the series, and haphazardly throughout the series all had clear urine during and immediately after bypass. All had an indwelling urinary catheter. Four to eight hours after return to the intensive care ward the urine of these patients, in the space of 30 to 60 minutes, became dark red in colour and was shown to contain haemoglobin. Haemolysis continued for 2 to 30 hours after its first recognition. There was confirmatory evidence of an elevated, sometimes grossly elevated, serum haemoglobin in all these patients. In all patients the urine was normal after 48 hours, in most after 18 hours. Delay in the appearance of haemoglobin in the urine may reflect the time taken to saturate serum haptoglobulins.
In the patients submitted to mitral valve replacement with the Starr-Edwards prosthesis or a mounted aortic homograft during this period, and throughout an extensive experience of valve replacement before this period, this syndrome was not observed. Other aspects of technique were unchanged. Where haemolysis has occasionally been seen in the past in relation to an operation with cardiopulmonary bypass, this has been related to prolonged bypass and has begun intraoperatively and continued with progressive diminution into early convalescence. It (14, 11, 11, 9 , and 6 days respectively). There is no correlation between early postoperative haemoglobinuria and late postoperative diminution in red cell survival, that is, patients in whom postoperative haemolysis was dramatic have been shown to have normal red cell survival figures; two who did not experience early postoperative haemolysis have been among those with the shortest red cell survival figures. Two patients have been admitted in late convalescence with haemoglobin figures of 6 and 5 5 g%-both these were children who had an associated iron deficiency with a low serum iron and an elevated total iron binding capacity. Two other patients with haemoglobin coneentrations of 10 and 9 7 g00 respectively were working and leading a normal life.
Two patients in the series cannot be traced. Patients were not initially placed on oral iron therapy at the time of discharge; they are now.
Those patients who have been traced are well, well-being in those who were grossly anaemic having been restored by appropriate transfusion and recourse to iron therapy.
Six patients have been catheterized in the postoperative period and have been shown to have gradients of 3 to 8 mmHg across the valve at rest. Of those submitted to postoperative investigation, two had large valves, one a medium, and one a small valve.
COMMENT
Mitral valve replacement is a safe and good operation. The ideal prosthetic valve has not yet been designed. It is doubtful whether any valve is free from the complications of thromboembolism, structural failure, infection, and blood destruction. While the design of the Beall valve has diminished the incidence of thromboembolism, its use is assoCiated with high incidence of early and late postoperative haemolysis. Early postoperative haemolysis is not recorded in other series either because it has not been recognized owing to the generally high incidence of postoperative haemolysis; because it has not occurred; or because it has not been reported. Late postoperative haemolysis is commonplace; of 12 patients recently recorded by Crexells et al. (1972) , haemolysis was a feature in all, and in six this was severe. While the consequences of haemolysis, unlike those of thromboembolism, can be largely remedied by appropriate iron therapy, severe haemolysis is a serious disadvantage and carries a high incidence of significant renal damage. has expressed the opinion that haemolysis in relation to the use of the Beall valve may diminish after the valve has been in situ for six months. If haemolysis is related to the use of Dacron velour it is clear that for this material the advantage of early tissue ingrowth cannot be claimed if haemolysis does in fact diminish only after six months.
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